SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-21-020775
Filing Date
2021-01-28
Accepted
2021-01-28 16:11:31
Documents
7

Document Format Files

Seq Description Document Type Size
1 424B5 d260304d424b5.htm 424B5 736445
2 GRAPHIC g260304g00a00.jpg GRAPHIC 25970
3 GRAPHIC g260304g10g27.jpg GRAPHIC 99747
4 GRAPHIC g260304g29d49.jpg GRAPHIC 117466
5 GRAPHIC g260304g47o32.jpg GRAPHIC 31047
6 GRAPHIC g260304g96y01.jpg GRAPHIC 276515
7 GRAPHIC g260304g99a99.jpg GRAPHIC 28633
  Complete submission text file 0001193125-21-020775.txt   1536276
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-228970 | Film No.: 21565074
SIC: 2834 Pharmaceutical Preparations